Tiziana Life Sciences Ltd

Market Cap

$157M

Healthcare·Biotechnology·🇺🇸 United States·NASDAQ

Healthcare·Biotechnology·🇺🇸·NASDAQ

Stock Price

$1.11-$0.49 (-30.62%)

Jul 15, 2026

52W High $2.5052W Low $1.08

Company Details

Tiziana Life Sciences Ltd, together with its subsidiaries, engages in the research and development of therapies for neurodegenerative and neuroinflammatory diseases in the United Kingdom and internationally. It develops Foralumab TZLS-401, ...

Leadership

Gabriele Marco Antonio Cerrone M.B.A.Founder

Founder & Executive Chairman

Keeren Shah

COO & CFO

Ivor R. Elrifi Ph.D.

CEO & Executive Director

William Edward Tente M.S.

Chief Regulatory Officer

Richard K. Kim M.D.

Chief Medical Officer

Napoleone Ferrara M.D.

Member of Scientific Advisory Board

IPO Date

Mar 24, 2000

Website

www.tizianalifesciences.com

Key Metrics TTM

Revenue

- YoY

Net Income

-$31M

EPS (Diluted)

Free Cash Flow

-$22M

Revenue / Share

Gross Margin

Operating Margin

Net Margin

FCF Margin

P/S

P/E

Revenue & Profitability

Operating Cash Flow

CapEx Spend

Stock-Based Compensation

OpEx Breakdown

War Chest (GBP)

Shares Outstanding